CYP2C19 gene, HLA DR gene, clinical practice, consumer advocacy, consumer attitude, drug efficacy, drug response, evidence based medicine, food and drug administration, gene, gene frequency, gene function, gene identification, genetic association, genetic screening, genotyping technique, human, marketing, medical research, pharmacogenetics, prediction, review, sensitivity and specificity, slco1b1 gene
dx.doi.org/10.2217/pgs.13.8, hdl.handle.net/1765/40825
Pharmacogenomics
Erasmus MC: University Medical Center Rotterdam

Kalf, R.R.J, Bakker, R, & Janssens, A.C.J.W. (2013). Predictive ability of direct-to-consumer pharmacogenetic testing: When is lack of evidence really lack of evidence?. Pharmacogenomics (Vol. 14, pp. 341–344). doi:10.2217/pgs.13.8